Key result
Remote ischemic conditioning did not increase 90-day functional independence (mRS 0-2) in acute ischemic stroke.
Why the study?
Up to half of patients with acute ischemic stroke experience poor functional recovery despite reperfusion therapy. Remote ischemic conditioning has been proposed as an adjunctive neuroprotective therapy, but evidence from randomized controlled trials remains inconsistent.
Does remote ischemic conditioning improve 90-day functional independence (mRS 0-2) compared with sham conditioning or standard care in adults with acute ischemic stroke?
Meta-Analysis (n=5,308)
Does remote ischemic conditioning improve 90-day functional independence (mRS 0-2) compared with sham conditioning or standard care in adults with acute ischemic stroke?
Answers are grounded in this paper and cite their sources.
Although safe, remote ischemic conditioning did not significantly improve 90-day functional independence in acute ischemic stroke across all trials, though a sensitivity analysis excluding high-risk-of-bias trials suggested a potential hypothesis-generating benefit (OR 1.16, p=0.019).
Background: Reperfusion therapy remains the standard of care for acute ischemic stroke (AIS), yet up to half of patients experience poor functional recovery even after successful recanalization. Remote ischemic conditioning (RIC) has been proposed as an adjunctive neuroprotective therapy, but evidence from randomized controlled trials (RCTs) remains inconsistent. We conducted a systematic review and meta-analysis to evaluate the effect of RIC on 90-day functional outcomes in patients with AIS. Methods: We systematically searched PubMed, the Cochrane Library, Scopus and ClinicalTrials.gov from inception through January 2026 for RCTs comparing RIC with sham conditioning or standard care in adults with AIS. The primary outcome was functional independence at 90 days (modified Rankin Scale [mRS] 0–2). Secondary efficacy outcomes were the ordinal mRS shift (common odds ratio), Barthel Index at 90 days, and National Institutes of Health Stroke Scale (NIHSS) score at ≤7 days or discharge. Safety outcomes were 90-day all-cause mortality, serious adverse events (SAEs), hemorrhagic transformation or symptomatic intracranial hemorrhage, and recurrent ischemic stroke or transient ischemic attack. Risk of bias was assessed with the Cochrane RoB 2 tool and certainty of evidence with GRADE. Pooled estimates were derived using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustment. Results: Fourteen RCTs enrolling 5,308 randomized participants met inclusion criteria. Twelve trials (4,049 analyzed participants) contributed to the primary outcome. RIC was not associated with a statistically significant increase in functional independence at 90 days (OR 1.17, 95% CI 0.99–1.39; p = 0.067; I² = 11.5%). The ordinal mRS shift analysis (7 trials) was similarly non-significant (common OR 1.17, 95% CI 0.98–1.40; p = 0.072), as were the Barthel Index (6 trials; MD 1.02, 95% CI −2.47 to 4.51; p = 0.485) and early NIHSS (7 trials; MD 0.17, 95% CI −0.38 to 0.72; p = 0.475). RIC did not increase 90-day all-cause mortality (OR 0.96, 95% CI 0.69–1.35; p = 0.817), SAEs (OR 0.90, 95% CI 0.72–1.12; p = 0.277), hemorrhagic transformation (RR 1.01, 95% CI 0.81–1.25; p = 0.936) or recurrent ischemic events (RR 0.87, 95% CI 0.62–1.23; p = 0.381). In a pre-specified sensitivity analysis excluding the five trials at high risk of bias, the remaining nine trials showed a statistically significant association with functional independence (OR 1.16, 95% CI 1.03–1.30; p = 0.019). Certainty of evidence was low for all outcomes. Conclusions: RIC was not associated with a statistically significant improvement in 90-day functional independence after AIS. RIC demonstrated a reassuring safety profile, with no increase in mortality, serious adverse events, or hemorrhagic complications. A sensitivity analysis excluding trials at high risk of bias suggested a possible benefit, but this was not pre-specified as a primary inference and is hypothesis-generating only. Current evidence does not support routine clinical implementation of RIC. Adequately powered trials with standardized conditioning protocols, and individual participant data meta-analysis, are required to determine whether a subgroup of patients derives benefit.
No takes yet. Share an insight, caveat, or question.
Shams et al. (2026) conducted a meta-analysis in Acute ischemic stroke (AIS) (n=5,308). Remote ischemic conditioning (RIC) vs. Sham conditioning or standard care was evaluated on Functional independence at 90 days (modified Rankin Scale [mRS] 0-2) (OR 1.17, 95% CI 0.99-1.39, p=0.067). Remote ischemic conditioning did not increase 90-day functional independence (mRS 0-2) in acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: